FDA Targets Pharmacies' Hormone Drug Marketing

Law360, New York (January 9, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration took action against seven pharmacy operations on Wednesday, warning them that medical evidence does not support claims they make about their bioidentical hormone replacement drugs.

Claims that the bioidentical hormone drugs prevent Alzheimer's disease, strokes, heart disease and various forms of cancer are misleading, the FDA charged in letters sent to the pharmacies. The FDA said the inaccurate statements violate federal laws.

“We want to assure that Americans receive accurate information about the risks and benefits of drug therapies,” said...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.